Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Pablo Barreiro, Fernando de Jesus, Octavio Corral & Carmen de Mendoza. (2023) Safety considerations in the management of hepatitis C and HIV co-infection. Expert Opinion on Drug Safety 22:5, pages 363-372.
Read now
Read now
Vicente Soriano, Pablo Labarga, José V. Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M. Peña & Pablo Barreiro. (2017) Drug interactions in HIV-infected patients treated for hepatitis C. Expert Opinion on Drug Metabolism & Toxicology 13:8, pages 807-816.
Read now
Read now
Vicente Soriano, Jose Vicente Fernandez-Montero, Laura Benitez-Gutierrez, Carmen de Mendoza, Ana Arias, Pablo Barreiro, José M. Peña & Pablo Labarga. (2017) Dual antiretroviral therapy for HIV infection. Expert Opinion on Drug Safety 16:8, pages 923-932.
Read now
Read now
Isabella Esposito, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M Peña & Vicente Soriano. (2015) Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects. Expert Opinion on Drug Safety 14:9, pages 1421-1434.
Read now
Read now
José Vicente Fernández-Montero, Eugenia Vispo & Vicente Soriano. (2014) Emerging antiretroviral drugs. Expert Opinion on Pharmacotherapy 15:2, pages 211-219.
Read now
Read now
Articles from other publishers (10)
C. Muddu Krishna, J. N. Kolla, Hari Babu Bollikolla, T. Sravan Kumar Reddy & S. Asha. (2023) Ethyl Gallate: Promising Cytoprotective against HIV-1-Induced Cytopathy and Antiretroviral-Induced Cytotoxicity. Advances in Virology 2023, pages 1-8.
Crossref
Crossref
Stamatia C. Vorri, Ilias Christodoulou, Styliani Karanika & Theodoros Karantanos. (2023) Human Immunodeficiency Virus and Clonal Hematopoiesis. Cells 12:5, pages 686.
Crossref
Crossref
Mary S. Pampusch, Hadia M. Abdelaal, Emily K. Cartwright, Jhomary S. Molden, Brianna C. Davey, Jordan D. Sauve, Emily N. Sevcik, Aaron K. Rendahl, Eva G. Rakasz, Elizabeth Connick, Edward A. Berger & Pamela J. Skinner. (2022) CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection. PLOS Pathogens 18:2, pages e1009831.
Crossref
Crossref
Lauren Greenberg, Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Therese Staub, Martin Gisinger, Michael Skoll, Huldrych F Günthard, Alexandra Scherrer, Cristina Mussini, Colette Smith, Margaret Johnson, Stéphane De Wit, Coca Necsoi, Christian Pradier, Ferdinand Wit, Clara Lehmann, Antonella d’Arminio Monforte, Jose M Miró, Antonella Castagna, Vincenzo Spagnuolo, Anders Sönnerborg, Matthew Law, Jolie Hutchinson, Nikoloz Chkhartishvili, Natalia Bolokadze, Jan-Christian Wasmuth, Christoph Stephan, Vani Vannappagari, Felipe Rogatto, Josep M Llibre, Claudine Duvivier, Jennifer Hoy, Mark Bloch, Heiner C Bucher, Alexandra Calmy, Alain Volny Anne, Annegret Pelchen-Matthews, Jens D Lundgren, Lars Peters, Loveleen Bansi-Matharu, Amanda Mocroft, F Wit, P Reiss, M Hillebregt, M Law, K Petoumenos, N Rose, R Zangerle, H Appoyer, S De Wit, M Delforge, G Wandeler, C Stephan, M Bucht, N Chkhartishvili, O Chokoshvili, A d’Arminio Monforte, A Rodano, A Tavelli, I Fanti, C Mussini, V Borghi, C Pradier, E Fontas, K Dollet, C Caissotti, J Casabona, J M Miro, J M Llibre, A Riera, J Reyes- Urueña, C Smith, F Lampe, A Castagna, A Lazzarin, A Poli, A Sönnerborg, K Falconer, V Svedhem, H Günthard, B Ledergerber, H Bucher, A Scherrer, J C Wasmuth, J J Vehreschild, G Fätkenheuer, A Mocroft, J Rooney, F Rogatto, V Vannappagari, H Garges, G Wandeler, M Law, R Zangerle, C Smith, S De Wit, J Lundgren, H Günthard, J Lundgren, H Günthard, J Kowalska, D Raben, L Ryom, A Mocroft, J Rockstroh, L Peters, A Volny Anne, N Dedes, E D Williams, N Chkhartishvili, R Zangerle, M Law, F Wit, C Necsoi, G Wandeler, C Stephan, C Pradier, A D’Arminio Monforte, C Mussini, A Bruguera, H Bucher, A Sönnerborg, J J Vehreschild, J C Wasmuth, C Smith, A Castagna, F Rogatto, R Haubrich, V Vannappagari, H Garges, L Ryom, A Mocroft, B Neesgaard, L Greenberg, L Bansi-Matharu, V Svedhem-Johansson, F Wit, K Grabmeier-Pfistershammer, R Zangerle, J Hoy, M Bloch, D Braun, A Calmy, G Schüttfort, M Youle, S De Wit, C Mussini, S Zona, A Castagna, A Antinori, N Chkhartishvili, N Bolokadze, E Fontas, K Dollet, C Pradier, J M Miro, J M Llibre, J J Vehreschild, C Schwarze-Zander, J -C Wasmuth, J Rockstroh, K Petoumenos, M Law, C Duvivier, G Dragovic, R Radoi, C Oprea, M Vasylyev, J Kowalska, R Matulionyte, V Mulabdic, G Marchetti, E Kuzovatova, N Coppola, J Begovac, I Aho, S Martini, H Bucher, A Harxhi, T Wæhre, A Pharris, A Vassilenko, G Fätkenheuer, J Bogner, A Maagaard, E Jablonowska, D Elbirt, G Marrone, C Leen, C Wyen, M Kundro, N Dedes, E Dixon Williams, J Gallant, D Thorpe, H Diaz Cuervo, V Vannappagari, H Garges, A Volny-Anne, N Dedes, L Mendao, E Dixon Williams, D Raben, L Peters, L Ryom, B Neesgaard, J F Larsen, M L Jakobsen, T Bruun, A Bojesen, E V Hansen, T W Elsing, D Kristensen, S Thomsen, T Weide, A Mocroft, L Greenberg, A Mocroft, L Greenberg, L Bansi-Matharu, A Pelchen-Matthews, K Petoumenos, N Rose & D Byonanebye. (2021) Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus. Clinical Infectious Diseases 73:7, pages e2323-e2333.
Crossref
Crossref
Carmen de Mendoza & Vicente Soriano. (2020) Tough requirements for new antiretroviral drugs. The Lancet HIV 7:3, pages e150-e151.
Crossref
Crossref
Thomas Maitre, Patrice Muret, Mathieu Blot, Anne Waldner, Michel Duong, Ali SI-Mohammed, Pascal Chavanet, Serge Aho & Lionel Piroth. (2019) Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice. Current HIV Research 17:3, pages 190-197.
Crossref
Crossref
Anjie Zhen, Mayra A Carrillo & Scott G Kitchen. (2017) Chimeric antigen receptor engineered stem cells: a novel HIV therapy. Immunotherapy 9:5, pages 401-410.
Crossref
Crossref
Beth Rachlis, Rakhi Karwa, Celia Chema, Sonak Pastakia, Sten Olsson, Kara Wools-Kaloustian, Beatrice Jakait, Mercy Maina, Marcel Yotebieng, Nagalingeswaran Kumarasamy, Aimee Freeman, Nathalie de Rekeneire, Stephany N. Duda, Mary-Ann Davies & Paula Braitstein. (2016) Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Safety 39:10, pages 959-976.
Crossref
Crossref
Li Liu, Bhavik Patel, Mustafa H. Ghanem, Virgilio Bundoc, Zhili Zheng, Richard A. Morgan, Steven A. Rosenberg, Barna Dey & Edward A. Berger. (2015) Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity. Journal of Virology 89:13, pages 6685-6694.
Crossref
Crossref
H Samji, TE Taha, D Moore, AN Burchell, A Cescon, C Cooper, JM Raboud, MB Klein, MR Loutfy, N Machouf, CM Tsoukas, JSG Montaner & RS Hogg. (2015) Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada. HIV Medicine 16:2, pages 76-87.
Crossref
Crossref